ESR1 and breast carcinoma: Breast cancers that do not express the estrogen receptor (ER) and the progesterone receptor (PR) and that do not overexpress human epidermal growth factor receptor 2 (HER2) are collectively grouped as triple-negative breast cancer (TNBC).